Cart summary

You have no items in your shopping cart.

PI3K-IN-22

SKU: orb1694052

Description

PI3K-IN-22 is a potent dual inhibitor of PI3Kα and mTOR, demonstrating IC50 values of 0.9 nM and 0.6 nM, respectively. It is a valuable research tool for investigating the PI3K/AKT/mTOR signaling pathway in cancer, with applications in both in vitro cellular assays and in vivo preclinical studies.

Research Area

Signal Transduction

Images & Validation

Key Properties

CAS Number1202884-94-3
MW624.66
FormulaC31H35F3N8O3
SMILESO=C(NC=1C=CC(=CC1)C=2N=C3C(C=CN3CC(F)(F)F)=C(N2)N4CCOCC4)NC5=CC=C(C=C5)C(=O)N(C)CCN(C)C
TargetmTOR,Others,PI3K

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • PI3Kα-IN-22 [orb2565520]

    2925030-26-6

    467.47

    C24H23F2N5O3

    50 mg, 100 mg, 25 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

PI3K-IN-22 (orb1694052)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%